See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070494_2018_Acadia_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 223807000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001070494, Acadia Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 373,477,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,538,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,662,000 |
| 3 | remainder_Assets | 2,829,000 |
| 4 | LiabilitiesCurrent | 49,030,000 |
| 5 | LiabilitiesNoncurrent | 191,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 596,202,884 |
| 9 | ResearchAndDevelopmentExpense | 396,537,231 |
| 10 | remainder_Expenses | 56,296,960 |
| 11 | remainder_Revenues | 662,462,737 |
| 12 | remainder_NetIncome | 5,259,872 |
| 13 | remainder_ComprehensiveNetIncome | 93,086 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 384,506,000 |
| 1 | Liabilities | 49,221,000 |
| 2 | Expenses | 1,049,037,075 |
| 3 | Revenues | 662,462,737 |
| 4 | StockholdersEquity | 335,285,000 |
| 5 | NetIncome | -381,314,466 |
| 6 | ComprehensiveNetIncome | -381,267,923 |
| 7 | BaseVar | 1,075,289,885 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.61 |
| 9 | EconomicCapitalRatio | 2.76 |
Edgar->Model Mapping
Feature Distribution
Change over Time
